ALK+ ALCL in the setting of adalimumab‐related hidradenitis suppurativa

Alexander Craig; Kwun Wah Wen

doi:10.1002/ccr3.7156

Clinical Case Reports (Apr 2023)

ALK+ ALCL in the setting of adalimumab‐related hidradenitis suppurativa

Alexander Craig,
Kwun Wah Wen

Affiliations

Alexander Craig: Department of Pathology University of California San Francisco USA
Kwun Wah Wen: Department of Pathology University of California San Francisco USA

DOI: https://doi.org/10.1002/ccr3.7156
Journal volume & issue: Vol. 11, no. 4
pp. n/a – n/a

Abstract

Read online

Abstract This ALK‐positive anaplastic large cell lymphoma (ALCL) case highlights the importance of considering ALCL in the setting of iatrogenic immunosuppression in hidradenitis suppurativa patients. Diagnosis of ALCL can be challenging in situations with very low viability/cellularity, negative CD3 and/or other T‐cell markers, and immunosuppression.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords